Brown JA - Search Results

1

Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer.

Cher ML, MacGrogan D, Bookstein R, Brown JA, Jenkins RB, Jensen RH. Cher ML, et al. Among authors: brown ja. Genes Chromosomes Cancer. 1994 Nov;11(3):153-62. doi: 10.1002/gcc.2870110304. Genes Chromosomes Cancer. 1994. PMID: 7530484

2

Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer.

Alcaraz A, Takahashi S, Brown JA, Herath JF, Bergstralh EJ, Larson-Keller JJ, Lieber MM, Jenkins RB. Alcaraz A, et al. Among authors: brown ja. Cancer Res. 1994 Aug 1;54(15):3998-4002. Cancer Res. 1994. PMID: 7518348

3

Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies.

Takahashi S, Qian J, Brown JA, Alcaraz A, Bostwick DG, Lieber MM, Jenkins RB. Takahashi S, et al. Among authors: brown ja. Cancer Res. 1994 Jul 1;54(13):3574-9. Cancer Res. 1994. PMID: 8012984

4

Chromosomal aneusomies detected by fluorescent in situ hybridization analysis in clinically localized prostate carcinoma.

Brown JA, Alcaraz A, Takahashi S, Persons DL, Lieber MM, Jenkins RB. Brown JA, et al. J Urol. 1994 Oct;152(4):1157-62. doi: 10.1016/s0022-5347(17)32527-2. J Urol. 1994. PMID: 8072085 Review.

5

Fluorescence in situ hybridization analysis of renal oncocytoma reveals frequent loss of chromosomes Y and 1.

Brown JA, Takahashi S, Alcaraz A, Borell TJ, Anderl KL, Qian J, Persons DL, Bostwick DG, Lieber MM, Jenkins RB. Brown JA, et al. J Urol. 1996 Jul;156(1):31-5. J Urol. 1996. PMID: 8648831

6

Simultaneous chromosome 7 and 17 gain and sex chromosome loss provide evidence that renal metanephric adenoma is related to papillary renal cell carcinoma.

Brown JA, Anderl KL, Borell TJ, Qian J, Bostwick DG, Jenkins RB. Brown JA, et al. J Urol. 1997 Aug;158(2):370-4. J Urol. 1997. PMID: 9224305

7

Aneusomies of chromosomes 8 and Y detected by fluorescence in situ hybridization are prognostic markers for pathological stage C (pt3N0M0) prostate carcinoma.

Takahashi S, Alcaraz A, Brown JA, Borell TJ, Herath JF, Bergstralh EJ, Lieber MM, Jenkins RB. Takahashi S, et al. Among authors: brown ja. Clin Cancer Res. 1996 Jan;2(1):137-45. Clin Cancer Res. 1996. PMID: 9816100

8

Fluorescence in situ hybridization aneuploidy as a predictor of clinical disease recurrence and prostate-specific antigen level 3 years after radical prostatectomy.

Brown JA, Slezak JM, Lieber MM, Jenkins RB. Brown JA, et al. Mayo Clin Proc. 1999 Dec;74(12):1214-20. doi: 10.4065/74.12.1214. Mayo Clin Proc. 1999. PMID: 10593349

9

Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens.

Qian J, Bostwick DG, Takahashi S, Borell TJ, Brown JA, Lieber MM, Jenkins RB. Qian J, et al. Among authors: brown ja. Am J Pathol. 1996 Oct;149(4):1193-9. Am J Pathol. 1996. PMID: 8863668 Free PMC article.

10

Metaphase analysis of metanephric adenoma reveals chromosome Y loss with chromosome 7 and 17 gain.

Brown JA, Sebo TJ, Segura JW. Brown JA, et al. Urology. 1996 Sep;48(3):473-5. doi: 10.1016/S0090-4295(96)00203-8. Urology. 1996. PMID: 8804507

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,272 results

Search Page

Filters